Skip to main content

Deal Alert: Aureos Capital invests $10-M in Central India Hospotal Chain BSR Super Specialty Hospitals

From the Press Release

Funds managed by Aureos Capital have completed a $10m investment in the BSR Super Speciality Hospitals Limited (BSR), a leading Indian healthcare group.

Aureos Capital Limited is a private equity fund management company specialising in investing in small and medium sized businesses in emerging markets.



BSR currently owns and operates six diagnostic centres and two major hospitals across five cities in Central India. The hospitals include a 175-bed tertiary hospital (BSR Super Specialty Hospital, Bhilai) and the first specialist cancer hospital (BSR Cancer Hospital) in the state of Chattisgarh.

BSR Super Specialty Hospital is the first tertiary care hospital in the region, providing thousands of patients to date with previously unattainable levels of care.

BSR Cancer Hospital, the first specialist private sector cancer hospital in Chattisgarh state, is currently undergoing an extensive remodelling to increase quality and depth of its cancer care offering.

BSR Hospitals also owns Bhilai Scan and Research Limited (BSRL), who operate imaging diagnostics centres fully equipped with radiology and pathology services, across Central India.

BSR’s strategic alignment with Aureos will pave the way for continued expansion in its network of hospitals and diagnostic centres in wider geographies. BSR Hospital intends to start nine new imaging diagnostic centres and several new hospitals in the region, including a 150-bed multi-specialty hospital in Nagpur and a hospital in Rajnandgaon.

Analysts expect the hospital and diagnostic services market in India to grow at 20% per annum. G.V. Kumar, Partner of Aureos in India, comments: “The Indian healthcare sector, particularly in the underserved region of Central India is chronically under-funded, which has created a huge demand for private investment in the Indian hospital industry.”

Statistics reveal that there are 3,316 people to every hospital bed in Central India. The government aims to reduce this to one for every 800 people, suggesting that private sector investment will need to play a major role in increasing hospital capacity.

G.V. Kumar comments: “BSR Hospitals, driven by the visionary Dr. Khanduja, is a well-established healthcare group and a recognised brand. Its continued expansion into many of India’s most overlooked regions makes both a compelling investment case but has obvious benefits for the region’s population.”

“As well as providing critical healthcare services to the region, BSR Hospitals’ consultative status allows students to train within the facility, creating more doctors and healthcare professionals in an area that is widely expected to require an injection of medical expertise to cope with the growing population.”

The company has recently completed a deal with the Medica Synergie Group in Kolkata, a 500-bed hospital, to manage their entire radiology department, marking the first time that the group will operate a diagnostic centre on behalf of another organisation.

Balaji Srinivas, Managing Partner of Aureos in India comments “Our aim is to offer management all the help they need to facilitate the growth of the healthcare group as it expands throughout Central India and looks to establish itself as the leading provider of healthcare facilities in Central India.”

“India’s rapidly growing middle class population is driving demand for healthcare services across Central India. Higher levels of disposable income per household as well as increased awareness of lifestyle related diseases such as cardiac ailments have led to increasing levels of health insurance amongst the population.”

“Aureos’ investment in BSR is in line with its philosophy of reaching the tier 2 cities in India to propel investment and growth. We intend to use our capital to expand into Tier 3 cities as well, where demand for quality affordable healthcare services outstrips supply. This is in line with Aureos India’s core strategy to move into underserved cities within India to invest in basic industries servicing the domestic market that provides attractive risk-adjusted returns by building sustainable business leaders of the future.”

BSR Hospitals was founded in 1993 by Dr. M K Khanduja, a leading Paediatrician in Bhilai. Dr.Khanduja, has figured in the “best 50 pathfinders” (entrepreneur doctors) published by Express Health Care magazine of The Indian Express group. Dr. Khanduja is the only person from all of Madhya Pradesh, Chhattisgarh, Orissa and Vidharbh to figure in this magazine.

Dr. M K Khanduja, Chairman & Managing Director of BSR Healthcare, comments: “Our growth story is a mirror of the need for far reaching changes impacting healthcare. We have been pioneers in bringing the modern medical technology to the region and have worked closely with the community to provide diagnostic and therapeutic services. We are sure that our growth plans will get a boost with partnering with Aureos. We will continue to focus on fulfilling the healthcare needs of the community at large.”

N. Muthuraman, Director at RiverBridge Investment Advisors Pvt. Ltd., comments: “It has been a truly satisfying experience to work with BSR Group in their maiden capital raising plan and Aureos India. We are proud to have assisted a first generation entrepreneur from an under-banked Tier 2 market such as Chhattisgarh in accessing mainstream capital. We had strong conviction on the investment proposition because of the significant growth potential in BSR Healthcare with its unique combination of diagnostic services and mid-size hospitals.”

BSR Super Speciality Hospitals Limited, owns and operates Apollo BSR Hospital, Bhilai, in association with Apollo Hospitals Enterprises Ltd. Chennai, the largest chain of healthcare providers in India. BSR Hospitals specialise in Cardiology, Cardio Thoracic, Oncology, Neurology, Orthopedic, Nephrology, Pediatrics, Urology, Gastroenterology and emergency care. The hospital aims to provide quality healthcare at affordable cost.

Popular posts from this blog

VC Interview: Shailendra Singh of Sequoia Capital India

In a recent interview to Venture Intelligence, Shailendra Singh discussed some of the firm’s newer investments in the early stage segment including in the online payments space, the progress at a few existing portfolio companies and the active role the firm is playing in helping its portfolio companies scale and succeed in India and globally. Prior to joining the firm in 2006, Singh was a strategy consultant at Bain & Company in New York and before that, an entrepreneur in the digital media industry. Venture Intelligence: How does Sequoia go about identifying potential early stage investments in India? Is there anything different you are doing today than, say, a couple of years back? Shailendra Singh: There is a lot more focus on technology investing and early stage investing. In general, as you might remember a few years ago, we were doing primarily growth investing but in the past 18-odd months, we have had a very strong focus on early stage and that’s continuing. In terms

ChrysCapital, Motilal Oswal PE & Sequoia named PE-VC Firms of the Decade

Press Release ChrysCapital, Motilal Oswal Private Equity and Sequoia Capital India have been named the top Private Equity & Venture Capital investors in India during the last decade, as part of Venture Intelligence’s APEX Awards. The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer.  While ChrysCapital won the “Private Equity Investor of the Decade” award, Motilal Oswal Private Equity was feted as India’s “Growth Capital Investor of the Decade”. The Indian arm of the storied Silicon Valley VC firm, Sequoia Capital, was named the country’s “Venture Capital Investor of the Decade”. The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms as well as "crowd sourced" nominations and voting from the Limited Partner, PE-VC and advisory communities. (The main criteria were Exit Track Record, New Fund Raises & Fo

Ambit tops League Table for Transaction Advisors to Private Equity deals in 2019

Ambit Corporate Finance topped the Venture Intelligence League Table for Transaction Advisor to Private Equity Transactions for the year 2019. Ambit advised PE deals worth $2.4 Billion (across 4 qualifying transactions) during the period. Citi ($1.1 Billion across 2 deals) and  Avendus  ($969 million across 12 deals) took the second and third spot. Edelweiss Financial Services ($758 million across 9 deals) and  PwC  ($708 million across 15 deals) completed the top five in 2019.  The  Venture Intelligence League Tables , the first such initiative exclusively tracking transactions involving India-based companies, are based on value of PE and M&A transactions advised by Financial and Legal Advisory firms. Ambit Corporate Finance advised the $1.9 Billion buyout of Pipeline Infrastructure from Reliance Industries   by Brookfield Asset Management  and the IFC and I Squared Capital-backed   Cube Highways' acquisition of Delhi-Agra Toll Road from Reliance Infrastructu

Jio deals help PE investments climb 12% in H1'20 to $18.8 B

Press Release With Reliance Industries' communications unit Jio Platforms attracting 51% of the investment value, Private Equity-Venture Capital (PE-VC) investments in India rose 12% during the first 6 months of 2020 to $18.8 Billion (across 341 deals), shows data from  Venture Intelligence , a research service focused on private company financials, transactions and their valuations. Investments totaling over $9.5 Billion in Jio by a troop of global private equity firms, following social media giant Facebook's $5.7 Billion mid April investment in the company, helped overall PE-VC investments better the $16.8 Billion (across 503 transactions) invested during the same period in 2019. (Note: These figures include Venture Capital investments, but exclude PE investments in Real Estate).   Jio Platforms' $9.5 Billion Private Equity haul (excluding Facebook’s strategic investment) was led by Middle Eastern and American investors with KKR, Saudi Arabia's Public Invest

Inventus, Sixth Sense, Blume & Norwest win Apex'20 Venture Capital Awards

Inventus Capital Partners, Sixth Sense Ventures, Blume Ventures and Norwest Venture Partners were voted the top Venture Capital investors in India during 2019. The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer. Other 2019 winners in the VC segment included  Axilor Ventures which was voted   the  Accelerator of the Year for the second year running, 3one4 Capital (VC Fund Raise of the Year) and Innoven Capital (Venture Debt firm of the Year). The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms as well as "crowd sourced" nominations and voting from the Limited Partner, PE-VC and advisory communities. (The main criteria are Exit Track Record, New Fund Raises & Follow-on Funding Rounds for Portfolio Companies).    " It is an honour to be recognised by entrepreneurs and investors as